688.98MMarket Cap-1860P/E (TTM)
1.890High1.810Low1.80MVolume1.820Open1.840Pre Close3.34MTurnover0.58%Turnover RatioLossP/E (Static)370.42MShares3.16052wk High1.19P/B574.49MFloat Cap1.57052wk Low--Dividend TTM308.87MShs Float49.455Historical High--Div YieldTTM4.35%Amplitude0.920Historical Low1.857Avg Price1Lot Size
Standard BioTools Stock Forum
assay services, kits and related revenue in 2024; and
-- Ended the quarter with cash, cash equivalents, restricted cash and
short-term investments of $464 million, after accounting for $71 million
cash payments for merger-related expenses, settlement of year-end
operating accruals, debt retirement and completed stock buybacks.
2 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE
Benzinga· 1 min ago
No comment yet